Low-cost and skilled workforces in China and India have positioned both countries as increasingly important manufacturing hubs for pharmaceutical companies, as they seek to contain costs while retaining quality outsourcing partners.
Despite the apparent inevitability of the contract manufacturing organization (CMO) sector’s growth in China and India, a recent wave of scandals has put significant dents in the reputations of both countries as locations for foreign firms to manufacture drugs. Rising costs have also caused some firms to question whether using one of the region’s many CMOs is worth the risk.
CONTENTS
4 CHALLENGES FOR OUTSOURCING TO ASIA
4 Bibliography
5 CONTRACT MANUFACTURING IN INDIA
6 Bibliography
7 LEADING CMO PLAYERS IN INDIA
9 CONTRACT MANUFACTURING IN CHINA
9 Bibliography
11 LEADING CMO PLAYERS IN CHINA
13 THE FUTURE OF THE CMO SECTOR IN INDIA AND CHINA
LIST OF TABLES
7 Table 1: Annual performance of the six leading CMOs headquartered in India, 2012–13 to
2013–14
11 Table 2: Annual performance of the six leading CMOs headquartered in China, 2012–13

Table 1: Annual performance of the six leading CMOs headquartered in India, 2012-13 to 2014-14